药物涂层球囊在冠状动脉慢性完全闭塞病变介入治疗中的应用  

Application of Drug-Coated Balloon in Intervention Treatment of Chronic Total Coronary Occlusion

作　　者：菲尔凯提·玉山江 蒋学俊[1] Feierkaiti·Yushanjiang;JIANG Xuejun(Department of Cardiology,Renmin Hospital of Wuhan Uniersity,Cardiovascular Research Institute,Wuhan University,Hubei Key Laboratory of Cardiology,Wuhan 430060,Hubei,China)

机构地区：[1]武汉大学人民医院心内科,武汉大学心血管病研究所,心血管病湖北省重点实验室,湖北武汉430060

出　　处：《心血管病学进展》2024年第1期62-64,69,共4页Advances in Cardiovascular Diseases

基　　金：中央高校基本科研业务费(2042021kf0132)。

摘　　要：药物涂层球囊(DCB)已成为冠状动脉介入治疗的有效手段之一,目前在支架内再狭窄、小血管病变、分叉病变中得到了广泛的应用。但在慢性完全闭塞(CTO)病变中应用的相关研究较少,现结合DCB的作用机制和DCB在CTO病变中应用的相关报道,阐述DCB在CTO病变中可能发挥的作用。Drug-coated balloon(DCB)has become one of the main methods for coronary artery intervention therapy,and is widely used in in-stent restenosis,small vessel lesions,and bifurcation lesions.There is limited research on the use of DCB in the treatment of chronic total occlusion(CTO)lesions.Therefore,this article will discuss the potential role of DCB in CTO lesions by combining their mechanism of action and relevant studies conducted in CTO patients.

关 键 词：药物涂层球囊 慢性完全闭塞病变 经皮冠状动脉介入治疗 

分 类 号：R541.4[医药卫生—心血管疾病]